Interpace Diagnostics Group's total assets for Q4 2025 were $33.84M, an increase of 181.14% from the previous quarter. IDXG total liabilities were $11.47M for the fiscal quarter, a -6.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.